Compelling evidence strongly implies that heparanase serve crucial roles in all aspects of the tumorigenic process, namely tumor initiation, growth, chemotherapy resistance, and metastasis [1–13], pointing to the potential of heparanase as an anti-cancer drug target and incentivizing the development of small molecular inhibitors of heparanase [14, 15]. This evidence concerns the gene HPSE and cancer.